NucS and drug resistance in Mycobacterium tuberculosis: potential for novel therapeutic targets
Main Article Content
Authors
B.Sh. Yakupov
L.N. Gumilyov Eurasian National University, 2 Satbayev street, Astana, 010000, The Republic of Kazakhstan
U.O. Zein
L.N. Gumilyov Eurasian National University, 2 Satbayev street, Astana, 010000, The Republic of Kazakhstan
A.M. Turgimbayeva
LLP «National Center of Biotechnology», 13/5 Kurgalzhynskoye road, Astana, 010000, The Republic of Kazakhstan
S.K. Abeldenov
LLP «National Center of Biotechnology», 13/5 Kurgalzhynskoye road, Astana, 010000, The Republic of Kazakhstan
Abstract
Antibiotic resistance of Mycobacterium tuberculosis poses a serious threat to global health. Kazakhstan is among the top 30 countries with the highest levels of multidrug-resistant tuberculosis and rifampicin-resistant tuberculosis. Existing antibiotics are losing effectiveness due to the rapid growth of drug resistance, which is why DNA repair enzymes of the pathogen are being considered as promising targets for new antibiotics. Unlike many other bacteria, M. tuberculosis lacks the classical mismatch repair system; instead, it employs an alternative pathway mediated by the endonuclease NucS. This article discusses the role of NucS in maintaining genomic stability in M. tuberculosis and its involvement in the development of antibiotic resistance. A review of experimental data shows that inactivation of NucS leads to a hypermutator phenotype, increasing the likelihood of the emergence of drug-resistant strains. These properties make NucS a promising target for antibacterial therapy. The study of NucS as a critically important protein in the pathogenesis and resistance of M. tuberculosis opens new avenues for the development of targeted drugs and strategies to suppress the development of resistance.
Keywords
tuberculosis, Mycobacterium tuberculosis, NucS, DNA repair, antibiotic resistance, therapeutic targets
Article Details
References
Tuberculosis: Causes and How It Spreads // U. S. CENTERS FOR DISEASE CONTROL AND PREVENTION. URL
Tuberculosis // World Health Organization. URL
Arrigoni R., Ballini A., Topi S., Bottalico L., Jirillo E., Santacroce L. Antibiotic resistance to Mycobacterium tuberculosis and potential use of natural and biological products as alternative anti-mycobacterial agents // Antibiotics. ‒ 2022 October. ‒ Vol. 11. No. 10. – P.1 – 15. //doi: 10.3390/antibiotics11101431.
Global Tuberculosis Report 2024 // World Health Organization. – Geneva: WHO, 2024. – P. 69.
Tuberculosis profile: Kazakhstan // World Health Organization. URL
Darby E.M., Trampari E., Siasat P., et al. Molecular mechanisms of antibiotic resistance revisited // Nature Reviews Microbiology. – 2023 Nov. – Vol. 21. – P. 280–295. //doi: 10.1038/s41579-022-00820-y.
Datta D., Jamwal S., Jyoti N., Patnaik S., Kumar D. Actionable mechanisms of drug tolerance and resistance in Mycobacterium tuberculosis // The FEBS Journal. – 2024 Oct. – Vol. 291. No 20. – P. 4433 – 4452. //doi: 10.1111/febs.17142.
Vander Beken S., Al Dulayymi JR., Naessens T., Koza G., Maza-Iglesias M., Rowles R., Theunissen C., De Medts J., Lanckacker E., Baird MS., Grooten J. Molecular structure of the Mycobacterium tuberculosis virulence factor, mycolic acid, determines the elicited inflammatory pattern // European Journal of Immunology. – 2011 Feb. – Vol. 41. No 2. – P. 450 – 460. //doi: 10.1002/eji.201040719.
Bailo R., Radhakrishnan A., Singh A. et al. The mycobacterial desaturase DesA2 is associated with mycolic acid biosynthesis // Scientific Reports. – 2022 Apr. – Vol. 12. Article No. 6943. //doi: 10.1038/s41598-022-10589-y.
te Brake L.H.M., de Knegt G.J., de Steenwinkel J.E., van Dam T.J.P., Burger D.M., Russel F.G.M., van Crevel R., Koenderink J.B., Aarnoutse R.E. The role of efflux pumps in tuberculosis treatment and their promise as a target in drug development: unraveling the black box // Annual Reviews. Pharmacol. Toxicol. – 2018 Jul. – Vol. 58. – P. 271–291. //doi: 10.1146/annurev-pharmtox-010617-052438.
Chakraborty P., Kumar A. The extracellular matrix of mycobacterial biofilms: could we shorten the treatment of mycobacterial infections? // Microbial Cell. – 2019 Jan. – Vol. 6. No 2. – P. 105 – 122. //doi: 10.15698/mic2019.02.667.
Sharma S., Mohler J., Mahajan SD., Schwartz SA., Bruggemann L., Aalinkeel R. Microbial biofilm: a review on formation, infection, antibiotic resistance, control measures, and innovative treatment // – 2023 Jun. – Vol. 11. No 6 – Article No. 1614. //doi: 10.3390/microorganisms11061614.
Kurthkoti K., Kumar P., Sang PB., Varshney U. Base excision repair pathways of bacteria: new promise for an old problem // Future Medicinal Chemistry. – 2020 Feb. – Vol. 12. No 4. – P. 339-355. //doi: 10.4155/fmc-2019-0267.
Revitt-Mills SA., Wright EK., Vereker M., O'Flaherty C., McPherson F., Dawson C., van Oijen AM., Robinson A. Defects in DNA double-strand break repair resensitize antibiotic-resistant Escherichia coli to multiple bactericidal antibiotics // Microbiology Open. – 2022 Oct. – Vol. 11. No 5. – P. 31. //doi: 10.1002/mbo3.1316.
Mo C, Y., Manning S. A., Roggiani M., Culyba M. J., Samuels A. N., Sniegowski P. D., Goulian M., Kohli R. M. Systematically altering bacterial SOS activity under stress reveals therapeutic strategies for potentiating antibiotics // mSphere. – 2016 Aug. – Vol. 1. No 4. P. 1-15. //doi: 10.1128/mSphere.00163-16.
Bellio P., Mancini A., Di Pietro L., Cracchiolo S., Franceschini N., Reale S., de Angelis F., Perilli M., Amicosante G., Spyrakis F., Tondi D., Cendron L., Celenza G. Inhibition of the transcriptional repressor LexA: Withstanding drug resistance by inhibiting the bacterial mechanisms of adaptation to antimicrobials // Life Sciences. – 2020 Jan. Vol. 241. – P. 1-19. //doi: 10.1016/j.lfs.2019.117116.
Memar M. Y., Yekani M., Celenza G., Poortahmasebi V., Naghili B., Bellio P., Baghi H. B. The central role of the SOS DNA repair system in antibiotics resistance: A new target for a new infectious treatment strategy // Life Sciences. – 2020 Dec. Vol. 262. – P. 1-11. //doi: 10.1016/j.lfs.2020.118562.
Reiche M. A, Warner D. F, Mizrahi V. Targeting DNA replication and repair for the development of novel therapeutics against tuberculosis // Frontiers in Molecular Biosciences. – 2017 Nov. Vol. 4. – P 1-18. //doi: 10.3389/fmolb.2017.00075.
van der Veen S, Tang C. M. The BER necessities: the repair of DNA damage in human-adapted bacterial pathogens // Nature Reviews Microbiology. – 2015 Feb. Vol. 13. No 2. – P. 1-12. // doi: 10.1038/nrmicro3391.
Singh A. Guardians of the mycobacterial genome: a review on DNA repair systems in Mycobacterium tuberculosis // Microbiology society. – 2017 Dec. Vol. 163, No 12. – P. 1740-1758. //doi: 10.1099/mic.0.000578.
Huffman J. L., Sundheim O., Tainer J. A. DNA base damage recognition and removal: new twists and grooves // Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. – 2005 Sep. Vol. 577. No 2. – P. 55–76. //doi: 10.1016/j.mrfmmm.2005.03.012.
Dianov G., Lindahl T. Reconstitution of the DNA base excision repair pathway // Current Biology. – 1994 Dec. Vol. 4. No 12. – P. 1069–1076. //doi: 10.1016/s0960-9822(00)00245-1.
Sancar A, Rupp W. D. A novel repair enzyme: UVRABC excision nuclease of Escherichia coli cuts a DNA strand on both sides of the damaged region // Cell. – 1983 May. Vol. 33. No 1. – P. 249–260. //doi: 10.1016/0092-8674(83)90354-9.
Verhoeven E. A., Wyman C., Moolenaar, Geri F., Goosen N. The presence of two UvrB subunits in the UvrAB complex ensures damage detection in both DNA strands // The Embo Journal. – 2002 Aug. Vol. 21. – P. 4196–4205. //doi: Crossref.
Reardon J. T, Sancar A. Nucleotide excision repair // Progress in Nucleic Acid Research and Molecular Biology. – 2005. Vol. 79. – P. 183–235. //doi: 10.1016/S0079-6603(04)79004-2
Oivanen M., Kuusela S., Lönnberg H. Kinetics and mechanisms for the cleavage and isomerization of the phosphodiester bonds of RNA by brønsted acids and bases // Chemical Revews. – 1998 Apr. Vol. 98. No 3. – P. 961– 990. //doi: 10.1021/cr960425x.
Vaisman A., Woodgate R. Redundancy in ribonucleotide excision repair: competition, compensation, and cooperation // DNA Repair. – 2015 May. Vol. 29. – P. 74–82. //doi: 10.1016/j.dnarep.2015.02.008.
Gupta R., Barkan D., Redelman-Sidi G., Shuman S., Glickman M. S. Mycobacteria exploit three genetically distinct DNA doublestrand break repair pathways // Molecular Microbiology. – 2011 Nov. Vol. 79. No 2. – P. 316–330. //doi: 10.1111/j.1365-2958.2010.07463.x.
Iyer, R. R., Pluciennik, A., Burdett, V., Modrich P. L. DNA mismatch repair: functions and mechanisms // Chemical Reviews. – 2005 Dec. Vol. 106. No 2. – P. 302–323. //doi: 10.1021/cr0404794.
Castañeda-García A, Prieto A. I., Rodríguez-Beltrán J., Alonso N., Cantillon D., Costas C., Pérez-Lago L., Zegeye E.D., Herranz M., Plociński P., Tonjum T., García de Viedma D., Paget M., Waddell S. J., Rojas A. M., Doherty A. J., Blázquez J. A non-canonical mismatch repair pathway in prokaryotes // Nature Communications. – 2017 Jan. Vol. 8. Article No. 14246. – P. 1-10. //doi: 10.1038/ncomms14246.
Rezgui R., Lestini R., Kühn J., Fave X., McLeod L., Myllykallio H., Alexandrou A., Bouzigues C. Differential interaction kinetics of a bipolar structure-specific endonuclease with DNA flaps revealed by single-molecule imaging // PLOS One. – 2014 Nov. Vol. 9. No 11. Article No. e113493. //doi: 10.1371/journal.pone.0113493.
Ren B., Kühn J., Meslet-Cladiere L., Briffotaux J., Norais C., Lavigne R., Flament D., Ladenstein R., Myllykallio H. Structure and function of a novel endonuclease acting on branched DNA substrates // The EMBO Journal. – 2009 Aug. Vol. 28. No 16. – P. 2479–2489. //doi: 10.1038/emboj.2009.192.
Cebrián-Sastre E., Martín-Blecua I., Gullón S., Blázquez J., Castañeda-García A. Control of Genome Stability by EndoMS/NucS-Mediated Non-Canonical Mismatch Repair // Cells. – 2021 May. Vol, 10. No 6. – P. 13–15. //doi: 10.3390/cells10061314.
Busch, C. R., DiRuggiero J. MutS and MutL are dispensable for maintenance of the genomic mutation rate in the halophilic archaeon Halobacterium salinarum NRC-1 // PLOS One. – 2010 Feb. Vol. 5. No 2. Article No. e9045. //doi: 10.1371/journal.pone.0009045.
Rock J.M., Lang U.F., Chase M.R., Ford C.B., Gerrick E.R., Gawande R., Coscolla M., Gagneux S., Fortune S.M., Lamers M.H. DNA replication fidelity in Mycobacterium tuberculosis is mediated by an ancestral prokaryotic proofreader // Nature Genetics. 2015 Jun. Vol. 47. No 6. – P. 1–5. //doi: 10.1038/ng.3269.
Ishino S., Nishi Y., Oda S., Uemori T., Sagara T., Takatsu N., Yamagami T., Shirai T., Ishino Y. Identification of a mismatch-specific endonuclease in hyperthermophilic Archaea // Nucleic Acids Research. – 2016 Apr. Vol. 44. No 7. – P. 2977–2986. //doi: 10.1093/nar/gkw153.
Zhang L., Jiang D., Wu M., Yang Z., Oger P. M. New Insights Into DNA Repair Revealed by NucS Endonucleases From Hyperthermophilic Archaea // Frontiers in Microbiology. – 2020 Jul. Vol. 11. Article No. 1263. //doi: 10.3389/fmicb.2020.01263.
Dagva O., Thibessard A., Lorenzi J. N., Labat V., Piotrowski E., Rouhier N., Myllykallio H., Leblond P., Bertrand C. Correction of non-random mutational biases along a linear bacterial chromosome by the mismatch repair endonuclease NucS // Nucleic Acids Reseacrh. – 2024 May. Vol. 52. No 9. – P. 5033-5047. //doi: 10.1093/nar/gkae132.
Nakae S., Hijikata A., Tsuji T., Yonezawa K., Kouyama KI., Mayanagi K, Ishino S., Ishino Y., Shirai T. Structure of the EndoMS-DNA Complex as Mismatch Restriction Endonuclease // Structure. – 2016. Vol. 24. No 11. – P. 1960-1971. //doi: 10.1016/j.str.2016.09.005.
Zhang L., Shi H., Gan Q., Wang Y., Wu M., Yang Z., Oger P., Zheng J. An alternative pathway for repair of deaminated bases in DNA triggered by archaeal NucS endonuclease // DNA Repair. – 2020 Jan. Vol 85. – P. 1-32. //doi: 10.1016/j.dnarep.2019.102734.